Greater Cannabis Company (GCAN) Equity Average (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Equity Average of -$758337.0 in Q1 2026, up 18.02% quarter-over-quarter from -$924995.5 in Q4 2025, and up 8.87% on a YoY basis from -$696566.8 in Q1 2025.
Greater Cannabis Company (GCAN) Equity Average (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Equity Average history runs 10 years deep, the most recent figure standing at -$758337.0 for Q1 2026.
- In Q1 2026, Equity Average rose 8.87% year-over-year to -$758337.0; the TTM figure through Mar 2026 stood at -$758337.0 (up 8.87% YoY), while the FY2025 annual figure was -$790961.0, down 5.36% from the prior year.
- Equity Average was -$758337.0 for Q1 2026 at Greater Cannabis Company, up from -$924995.5 in the prior quarter.
- In the past five years, Equity Average ranged from a high of -$542905.0 in Q1 2022 to a low of -$1.1 million in Q3 2025.
- Historically, Equity Average has averaged -$727009.7 across 5 years, with a median of -$683537.5 in 2024.
- The sharpest annual moves came in 2022 and 2026: Equity Average tumbled 234.95% in 2022, then increased 8.87% in 2026.
- A 5-year view of Equity Average shows it stood at -$553129.5 in 2022, then fell by 18.56% to -$655801.5 in 2023, then slipped by 24.82% to -$818599.0 in 2024, then fell by 13.0% to -$924995.5 in 2025, then grew by 18.02% to -$758337.0 in 2026.
- The last three Equity Average figures came in at -$758337.0 (Q1 2026), -$924995.5 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | Greater Cannabis Company | - | - | - | -758,337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -758,337.00 |
| Dec 31, 2025 | -924,995.50 |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -948,113.50 |
| Mar 31, 2025 | -832,128.50 |
| Dec 31, 2024 | -818,599.00 |
| Sep 30, 2024 | -773,842.50 |
| Jun 30, 2024 | -728,301.50 |
| Mar 31, 2024 | -683,537.50 |
| Dec 31, 2023 | -655,801.50 |
| Sep 30, 2023 | -641,656.00 |
| Jun 30, 2023 | -610,419.50 |
| Mar 31, 2023 | -566,364.00 |
| Dec 31, 2022 | -553,129.50 |
| Sep 30, 2022 | -601,541.00 |
| Jun 30, 2022 | -629,200.50 |
| Mar 31, 2022 | -542,905.00 |
| Dec 31, 2021 | -370,896.50 |
| Sep 30, 2021 | -179,591.50 |
| Jun 30, 2021 | -217,684.50 |